EssilorLuxottica (OTCMKTS:ESLOY) Hits New 52-Week Low – Should You Sell?

EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOYGet Free Report)’s stock price reached a new 52-week low during trading on Thursday . The stock traded as low as $91.44 and last traded at $91.85, with a volume of 38013 shares trading hands. The stock had previously closed at $93.88.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on the company. Deutsche Bank Aktiengesellschaft assumed coverage on EssilorLuxottica in a report on Tuesday, May 12th. They issued a “hold” rating on the stock. The Goldman Sachs Group lowered EssilorLuxottica from a “buy” rating to a “hold” rating in a research report on Tuesday, July 14th. Finally, Zacks Research cut EssilorLuxottica from a “hold” rating to a “strong sell” rating in a research note on Tuesday, June 23rd. Two equities research analysts have rated the stock with a Strong Buy rating, four have assigned a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy”.

View Our Latest Research Report on ESLOY

EssilorLuxottica Trading Down 2.0%

The business’s 50 day moving average is $99.32 and its two-hundred day moving average is $120.06. The company has a current ratio of 0.99, a quick ratio of 0.70 and a debt-to-equity ratio of 0.17.

About EssilorLuxottica

(Get Free Report)

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.

Further Reading

Receive News & Ratings for EssilorLuxottica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EssilorLuxottica and related companies with MarketBeat.com's FREE daily email newsletter.